1. mAbDx Granted Approval for Development of Monoclonal Antibodies

    Mon 10 October 2011

    mAbDx granted IACUC approval for the development of monoclonal antibodies and immunoassays to identify and study mitochondrial DAMPs. Project title:  “Defining the contribution of mitochondrial damage-associated-molecular patterns (mtDAMPs) to the systemic inflammatory response syndrome (SIRS) after tissue injury”.

    read more
  2. EUROMIT 8 Research Report by CSO Michael Marusich: Non-invasive cheek swab sampling reveals mitochondrial dysfunction associated with HIV/AIDS antiretroviral therapy

    Mon 20 June 2011

    Research presentation by mAbDx CSO Michael Marusich at EUROMIT 8, The Eighth European Meeting on Mitochondrial Pathology “From mitochondrial diseases to mitochondria in health and disease”, Zaragoza, Spain. Title:  “OXPHOS Levels in Cheek Swabs Reveal Mitochondrial Dysfunction Associated with HIV/AIDS and/or Antiretroviral Therapy (ART).”

    read more

« Page 5 / 5